Tokyo (Japan) & online, 19-20/11/2022.
iToBoS was presented at the 86th Annual Meeting of the Tokyo Division of JDA, an online event.
Dr. Josep Malvehy, member of Fundació Clínic per a la Recerca Biomèdica, scientific partner of the iToBoS Project, presented the talk titled; “Dermoscopy, Total Body Photography, and beyond in the era of deep phenotyping”.
Multiple methods for the non-invasive evaluation of skin tumours have been introduced in the last decades in dermatology. Dermoscopy has been proved to aid in the diagnosis of melanocytic and epithelial carcinomas of the skin and more recently, the diagnostic features of inflammatory and other skin disorders were reported. In patients at risk of melanoma with atypical mole syndrome digital dermoscopy and total body photography allows the detection of new lesions and changes in melanocytic lesions that are the hallmark of malignancy in these patients. New developments in digital imaging have produced new TBP devices in 2D and 3D with higher resolution and polarised light. These devices, such as the proposed iToBoS Scanner, improve the images and allow faster and more accurate interpretation of the skin lesions.
Additionally, several optical methods such as reflectance confocal microscopy (RCM), and optical coherence tomography (OCT) of the skin or Line-Field OCT have added to the available diagnostic methods. Lastly, the advances in artificial intelligence (AI) have been used for image classification of skin tumours and detection of changes.
Dr Malvehy presented how iToBoS aims to use AI methods to integrate these ‘deep imaging’ technologies for skin, and combine with clinical data, pathology, genetics and molecular biology for deep phenotyping with the aim to improve risk stratification of patients for skin cancer and to improve the detection of malignant tumours.
Find more information at https://jdatokyo86.jp/english.html